Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - HNO International, Inc.Financial_Report.xls
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q/A
Amendment No. 1

 
(Mark One)

x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 31, 2011

or

¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE EXCHANGE ACT
 
Commission File Number: 333-130286
 
Clenergen Corporation
(Exact name of registrant as specified in its charter)

Nevada
 
20-2781289
(State or other jurisdiction of incorporation or organization)
 
(IRS Employer Identification No.)

3753 Howard Hughes Parkway
Suite 200, Las Vegas NV
USA
 
89169
(Address of principal executive offices)
  
(Zip Code)

+1 702 784 5921
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x Yes o No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or such shorted period that the registrant was required to submit and post such files).  o Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
 
Large accelerated filer o
Accelerated filer o
 
Non-accelerated filer o (Do not check if a smaller reporting company)  
Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  o Yes x No
 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of September 14, 2011, 151,639,191 shares of common stock of the issuer were outstanding.
 
 
 

 
 
Explanatory Note
 
The purpose of this amendment on Form 10-Q/A to Clenergen Corporation's quarterly report on Form 10-Q for the period ended July 31, 2011, filed with the Securities and Exchange Commission on September 20, 2011 (“Form 10-Q”), is solely to furnish Exhibit 101 to the Form 10-Q, as required by Rule 405 of Regulation S-T.
 
No other changes have been made to the Form 10-Q. This Form 10-Q/A speaks as of the original filing date of the Form 10-Q, does not reflect events that may have occurred subsequent to the original filing date, and does not modify or update in any way disclosures made in Form 10-Q.
 
Pursuant to Rule 406T of Regulation S-T, the interactive data files on Exhibit 101 hereto are deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act of 1933, as amended, are deemed not filed for purposes of section 18 of the Securities and Exchange Act of 1934, as amended, and otherwise are not subject to liability under those sections.
 
 
 

 

ITEM 6 – Exhibits
 
Exhibit No.
 
Description
10.7*  
Agreement, dated May 17, 2011, between Clenergen India Private Limited and Vastani Company S.A.
31.1*
 
Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.
31.2*
 
Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.
32.1*
 
Section 1350 Certification of Principal Executive Officer.
32.2*
 
Section 1350 Certification of Principal Financial Officer.
101.INS**
 
XBRL Instance Document
101.SCH**
 
XBRL Taxonomy Extension Schema
101.CAL**
 
XBRL Taxonomy Extension Calculation Linkbase
101.DEF**
 
XBRL Taxonomy Extension Definition Linkbase
101.LAB**
 
XBRL Taxonomy Extension Label Linkbase
101.PRE**
 
XBRL Taxonomy Extension Presentation Linkbase
 
*
Filed with our Form 10-Q as filed on September 20, 2011

**
Furnished with this Form 10-Q/A
 
 
 

 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated September 20, 2011      
Clenergen Corporation
   
 
By:
 
   
Mark L.M. Quinn
Executive Chairman and Chief Executive Officer of the Board
(Duly Authorized Officer
and Principal Executive Officer)
   
 
     
 
By:
 
   
Mike Starkie
Acting Chief Financial Officer
(Principal Financial and Accounting Officer)